W Grzeszczak
- Nephrology top 1%
- Dialysis and Renal Disease Management 15
-
- Diabetes Treatment and Management 23
- Diabetes Management and Research 19
- Hormonal Regulation and Hypertension 17
- Hematology top 5%
- Clinical Biochemistry top 5%
-
- Electrolyte and hormonal disorders 28
-
- Pharmacological Effects and Toxicity Studies 21
-
- Metabolism, Diabetes, and Cancer 20
-
- Diet and metabolism studies 16
- Co-authors
- E Zukowska-SzczechowskaDariusz MoczulskiB ŁackaMaciej TomaszewskiFadi J. CharcharMarcin ZychmaAnna F. DominiczakJanusz Gumprecht
- Partner nations
- PolandGermanyUnited Kingdom
In The Last Decade
W Grzeszczak
270 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 138
- Nephrology 614
- Endocrinology, Diabetes and Metabolism 969
- Cardiology and Cardiovascular Medicine 637
- Hematology 235
- Clinical Biochemistry 121
Countries citing papers authored by W Grzeszczak
This map shows the geographic impact of W Grzeszczak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W Grzeszczak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W Grzeszczak more than expected).
Fields of papers citing papers by W Grzeszczak
This network shows the impact of papers produced by W Grzeszczak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W Grzeszczak. The network helps show where W Grzeszczak may publish in the future.
Co-authorship network
The 25 scholars most cited alongside W Grzeszczak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Insuliny biopodobne jako alternatywa dla produktów oryginalnych | 2016 | 1 |
| 2 | 2016 | 30 | |
| 3 | Czy można zapobiegać rozwojowi cukrzycy typu 2 — co nowego opublikowano na ten temat na początku 2015 roku? | 2015 | 1 |
| 4 | 2014 | 3 | |
| 5 | Leczenie nowo rozpoznanej cukrzycy typu 2 w Polsce a najnowsze wytyczne. Wyniki polskiego badania ARETAEUS1 — komentarz | 2011 | 1 |
| 6 | Polish forum for prevention guidelines on metabolic syndrome. | 2010 | 2 |
| 7 | Consensus Statement on Self-Monitoring of Blood Glucose in Diabetes | 2009 | 5 |
| 8 | Consensus statement on self-monitoring of blood glucose in diabetes: A European perspective | 2009 | 17 |
| 9 | Brain-derived neurotrophic factor (BDNF) – a role in the pathogenesis of insulin resistance and type 2 diabetes mellitus | 2007 | 1 |
| 10 | Badanie PolDiab. Część I. Analiza leczenia cukrzycy w Polsce | 2006 | 3 |
| 11 | The PolDiab Study. Part I. Analysis of diabetes treatment in Poland | 2006 | 4 |
| 12 | 2004 | 9 | |
| 13 | Zasady insulinoterapii u chorych na cukrzycę typu 2 | 2003 | 0 |
| 14 | Sulfonylurea receptor gene 16-3 polymorphism - association with sulfonylurea or insulin treatment in type 2 diabetic subjects. | 2002 | 16 |
| 15 | Pozostałości pików oddechowych w widmie zmienności rytmu serca dorosłego człowieka z szybkim rytmem oddechowym i wolnym rytmem serca | 2002 | 2 |
| 16 | Independent Y chromosome markers associated with blood pressure and testosterone levels | 2002 | 1 |
| 17 | Frequency of the hemochromatosis C282Y and H63D mutations in a Polish population of Slavic origin. | 2001 | 23 |
| 18 | [Levels of beta-2-microglobulin (B2MG) in blood serum of patients during the early phase after kidney transplantation]. | 1993 | 2 |
| 19 | [Plasma levels of adrenaline and noradrenaline, plasma renin activity and arterial blood pressure in patients after kidney transplantation]. | 1991 | 3 |
| 20 | [Effect of naloxone on plasma renin activity and aldosteronemia in patients with chronic renal failure]. | 1989 | 0 |
About W Grzeszczak
W Grzeszczak is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology and Transplantation, having authored 298 papers that have together received 3.2k indexed citations. Recurring topics across this work include Electrolyte and hormonal disorders (28 papers), Diabetes Treatment and Management (23 papers), Pharmacological Effects and Toxicity Studies (21 papers), Metabolism, Diabetes, and Cancer (20 papers), Diabetes Management and Research (19 papers), Hormonal Regulation and Hypertension (17 papers), Diet and metabolism studies (16 papers) and Dialysis and Renal Disease Management (15 papers). The work is most often cited by research in Nephrology (614 citations), Endocrinology, Diabetes and Metabolism (969 citations) and Cardiology and Cardiovascular Medicine (637 citations). W Grzeszczak has collaborated with scholars based in Poland, Germany and United Kingdom. Frequent co-authors include E Zukowska-Szczechowska, Dariusz Moczulski, B Łacka, Maciej Tomaszewski, Fadi J. Charchar, Marcin Zychma, Anna F. Dominiczak, Janusz Gumprecht, Krzysztof Strojek and F Kokot. Their work appears in journals such as New England Journal of Medicine, Circulation and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.